Endogenous digitalis: pathophysiologic roles and therapeutic applications

被引:101
作者
Bagrov, Alexei Y. [1 ]
Shapiro, Joseph I. [2 ]
机构
[1] NIH, NIA, Intramural Res Program, Cardiovasc Sci Lab,Hypertens Unit, Baltimore, MD 21224 USA
[2] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43606 USA
来源
NATURE CLINICAL PRACTICE NEPHROLOGY | 2008年 / 4卷 / 07期
关键词
end-stage renal disease; endogenous cardiotonic steroids; hypertension; Na+/K+-ATPase; natriuretic hormone;
D O I
10.1038/ncpneph0848
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Endogenous digitalis-like factors, also called cardiotonic steroids, have been thought for nearly half a century to have important roles in health and disease. The endogenous cardiotonic steroids ouabain and marinobufagenin have been identified in humans, and an effector mechanism has been delineated by which these hormones signal through the sodium/ potassium-transporting ATPase. These findings have increased interest in this field substantially. Although cardiotonic steroids were first considered important in the regulation of renal sodium transport and arterial pressure, subsequent work has implicated these hormones in the control of cell growth, apoptosis and fibrosis, among other processes. This Review focuses on the role of endogenous cardiotonic steroids in the pathophysiology of essential hypertension, congestive heart failure, end-stage renal disease and pre-eclampsia. We also discuss potential therapeutic strategies that have emerged as a result of the increased understanding of the regulation and actions of cardiotonic steroids.
引用
收藏
页码:378 / 392
页数:15
相关论文
共 171 条
[1]
Adair CD, 1996, AM J NEPHROL, V16, P529
[2]
Adair D., 1997, AM, V10, p11A, DOI [10.1016/S0895-7061(97)88679-7, DOI 10.1016/S0895-7061(97)88679-7]
[3]
Cardiotonic steroids differentially affect intracellular Na+ and [Na+]i/[K+]i-independent signaling in C7-MDCK cells [J].
Akimova, OA ;
Bagrov, AY ;
Lopina, OD ;
Kamernitsky, AV ;
Tremblay, J ;
Hamet, P ;
Orlov, SN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (01) :832-839
[4]
Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain [J].
Amin, MS ;
Wang, HW ;
Reza, E ;
Whitman, SC ;
Tuana, BS ;
Leenen, FHH .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 289 (06) :R1787-R1797
[5]
HUMAN HYPERTENSIVE PLACENTA CONTAINS AN INCREASED AMOUNT OF NA,K-ATPASE WITH HIGHER AFFINITY FOR CARDIAC-GLYCOSIDES [J].
AMLER, E ;
CESTER, N ;
SALVOLINI, E ;
STAFFOLANI, R ;
BURKHARD, M ;
MAZZANTI, L ;
KOTYK, A ;
ROMANINI, C .
CELL BIOLOGY INTERNATIONAL, 1994, 18 (07) :723-727
[6]
Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives [J].
Anderson, David E. ;
Fedorova, Olga V. ;
Morrell, Christopher H. ;
Longo, Dan L. ;
Kashkin, Vladimir A. ;
Metzler, Jessica D. ;
Bagrov, Alexei Y. ;
Lakatta, Edward G. .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2008, 294 (04) :R1248-R1254
[7]
A clinical trial of the effects of dietary patterns on blood pressure [J].
Appel, LJ ;
Moore, TJ ;
Obarzanek, E ;
Vollmer, WM ;
Svetkey, LP ;
Sacks, FM ;
Bray, GA ;
Vogt, TM ;
Cutler, JA ;
Windhauser, MM ;
Lin, PH ;
Karanja, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124
[8]
ENDOGENOUS Na/K-ATPase INHIBITORS IN PATIENTS WITH PREECLAMPSIA [J].
Averina, I. V. ;
Tapilskaya, N. I. ;
Reznik, V. A. ;
Frolova, E. V. ;
Fedorova, O. V. ;
Lakatta, E. G. ;
Bagrov, A. Y. .
CELLULAR AND MOLECULAR BIOLOGY, 2006, 52 (08) :19-23
[9]
Endogenous marinobufagenin-like immunoreactive substance - A possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity [J].
Bagrov, AY ;
Dmitrieva, RI ;
Fedorova, OV ;
Kazakov, GP ;
Roukoyatkina, NI ;
Shpen, VM .
AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (10) :982-990
[10]
DIGITALIS-LIKE AND VASOCONSTRICTOR EFFECTS OF ENDOGENOUS DIGOXIN-LIKE FACTOR(S) FROM THE VENOM OF BUFO-MARINUS TOAD [J].
BAGROV, AY ;
ROUKOYATKINA, NI ;
FEDOROVA, OV ;
PINAEV, AG ;
UKHANOVA, MV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 234 (2-3) :165-172